JANX

Janux Therapeutics, Inc.

NasdaqGM · Healthcare

$15.34

-1.29% today

last filing 2026-06-11Pro sees filings in ~15 min

Price

hover · 4 moves explained

11 sells

Analyst consensus

$40.56target+164.4%vs $15.34 today

$14.00 low today target$80.00 high

16 analysts · ~12-month consensus · as of Jun 13. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q2 '25-17.3%

−$0.55

exp −$0.47

Q3 '25+36.3%

−$0.39

exp −$0.61

Q4 '25+20.5%

−$0.51

exp −$0.64

Q1 '26+25.0%

−$0.39

exp −$0.52

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-06-12	RA CAPITAL MANAGEMENT, L.P.	10% owner	—Indirect	5,500	—	—
Grant	2026-06-12	Simson Jake	Director	—Direct	5,500	—	—
Grant	2026-06-12	Kung Winston	Director	—Direct	5,500	—	—
Grant	2026-06-12	Hernday Natasha	Director	—Direct	5,500	—	—
Grant	2026-06-12	DOBMEIER ERIC	Director	—Direct	5,500	—	—

Grant

RA CAPITAL MANAGEMENT, L.P.

10% owner · 2026-06-12

—

5,500 shares

Grant

Simson Jake

Director · 2026-06-12

—

5,500 shares

Grant

Kung Winston

Director · 2026-06-12

—

5,500 shares

Grant

Hernday Natasha

Director · 2026-06-12

—

5,500 shares

Grant

DOBMEIER ERIC

Director · 2026-06-12

—

5,500 shares

34 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →